Fermata Advisors LLC bought a new stake in shares of INmune Bio, Inc. (NASDAQ:INMB – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 56,702 shares of the company’s stock, valued at approximately $384,000. A number of other […]